SEARCH

SEARCH BY CITATION

References

  • Abadie, J. J., Amardeilh, M. A. & Delverdier, M. E. (1999) Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. Journal of the American Veterinary Medical Association 215, 1629-1634
  • Al-Sarraf, R., Maudlin, G. N., Patnaik, A. K. & Meleo, K. A. (1996) A prospective study of radiation therapy for the treatment of grade 2 mast cell tumours in 32 dogs. Journal of Veterinary Internal Medicine 10, 376-378
  • Ayl, R. D., Couto, C. G., Hammer, A. S., Weisbrode, S., Ericson, J. G. & Mathes, L. (1992) Correlation of DNA ploidy to tumor histologic grade, clinical variables, and survival in dogs with mast cell tumors. Veterinary Pathology 29, 386-390
  • Bookbinder, P. F., Butt, M. T. & Harvey, H. J. (1992) Determination of the number of mast cells in lymph node, bone marrow and buffy coat cytological specimens in dogs. Journal of the American Veterinary Medical Association 200, 1648-1650
  • Bostock, D. (1973) The prognosis following surgical removal of mastocytomas in dogs. Journal of Small Animal Practice 14, 27-40
  • Bostock, D. E., Crocker, J., Harris, K. & Smith, P. (1989) Nucleolar organiser regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumours. British Journal of Cancer 59, 915-918
  • Davies, D. R., Wyatt, K. M., Jardine, J. E., Robertson, I. D. & Irwin, P. J. (2004) Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumours. Journal of the American Animal Hospital Association 40, 124-130
  • Dobson, J. M., Samuel, S., Milstein, H., Rogers, K. & Wood, J. L. N. (2002) Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. Journal of Small Animal Practice 43, 240-246
  • Dobson, J. M., Cohen, S. & Gould, S. (2004) Treatment of canine MCTs with prednisolone and radiotherapy. Veterinary and Comparative Oncology 2, 132-141
  • Dorn, C. R., Taylor, D. O., Schneider, R., Hibbard, H. H. & Klauber, M. R. (1968) Survey of animal neoplasms in Alameda and Contra Costa counties, California II. Cancer morbidity in dogs and cats from Alameda County. Journal of the National Cancer Institute 40, 307-318
  • Downing, S., Chien, M. B., Kass, P. H., Moore, P. E. & London, C. A. (2002) Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs. American Journal of Veterinary Research 63, 1718-1723
  • Duncan, J. (1999) The lymph nodes. In: Diagnostic Cytology and Haematology of the Dog and Cat. 2nd edn. Ed R. L.Cowell, R. D.Tyler & J. H.Meinkoth. Mosby, St Louis, MO, USA. pp 97-103
  • Frimberger, A. E., Moore, A. S., Larue, S. M., Gliatto, J. M. & Bengtson, A. E. (1997) Radiotherapy of incompletely resected, moderately differentiated mast cell tumours in the dog: 37 cases (1989 – 1993). Journal of the American Hospital Association 33, 320-324
  • Fulcher, R. P., Ludwog, L. L., Bergman, P. J., Newman, S. J., Simpson, A. M. & Patnaik, A. K. (2006) Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumours in dogs. Journal of the American Veterinary Medical Association 228, 210-215
  • Gerritsen, R. J., Teske, E., Kraus, J. S. & Rutteman, G. R. (1998) Multiagent chemotherapy for mast cell tumours in the dog. Veterinary Quarterly 20, 28-31
  • Goldschmidt, M. H. & Shofer, F. S. (1992) Skin Tumours of the Cat and Dog. Oxford, NY, USA: Pergamon Press
  • Grier, R. L., DiGuardo, G., Schaffer, C. B., Pedrosa, B., Myers, R., Merkley, D. F. & Thouvenelle, M. (1990) Mast cell tumour destruction by distilled water. American Journal of Veterinary Research 51, 1116-1120
  • Grier, R. L., DiGuardo, G., Myers, R. & Merkley, D. F. (1995) Mast cell tumour destruction in dogs by hypotonic solution. Journal of Small Animal Practice 36, 385-388
  • Hottendorf, G. H. & Nielsen, S. W. (1968) Pathologic report of 29 necropsies on dogs with mastocytoma. Pathologica Veterinaria 5, 102-121
  • Howard, E. B., Sawa, T. R., Nielsen, S. W. & Kenyon, A. J. (1969) Mastocytoma and gastroduodenal ulceration. Pathologica Veterinaria 6, 146-158
  • Jaffe, M. H., Hosgood, G., Kerwin, S. C., Hedlund, C. S. & Taylor, H. W. (2000) Deionised water as an adjunct for the treatment of canine cutaneous mast cell tumours. Journal of Small Animal Practice 41, 7-11
  • Jones, C. L., Grahn, R. A., Chien, M. B., Lyon, L. A. & London, C. A. (2004) Detection of c-kit mutations in canine mast cell tumors using fluorescent polyacrylamide gel electrophoresis. Journal of Veterinary Diagnostic Investigation 16, 95-100
  • Ladue, T., Price, G. S., Dodge, R., Page, R. L. & Thrall, D. E. (1998) Radiation therapy for incompletely resected canine mast cell tumours. Veterinary Radiology & Ultrasound 39, 57-62
  • Leibman, N. F., Lana, S. E., Hansen, R. A., Powers, B. E., Fettman, M. J., Withrow, S. J. & Ogilvie, G. K. (2000) Identification of matrix metalloproteinases in canine cutaneous mast cell tumors. Journal of Veterinary Internal Medicine 14, 583-586
  • London, C. (2004) Kinase inhibitors in cancer therapy. Veterinary and Comparative Oncology 2, 177-193
  • London, C. A., Kisseberth, W. C., Galli, S. J., Geissler, E. N. & Helfand, S. C. (1996) Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine MCTs. Journal of Comparative Pathology 115, 399-414
  • London, C. A., Galli, S. J., Yuuki, T., Hu, Q.-Q., Helfand, S. C. & Geissler, E. N. (1999) Spontaneous canine MCTs express tandem duplications in the proto-oncogene c-kit. Experimental Haematology 27, 689-697
  • London, C., Hannah, A. L., Zadovoskaya, R., Chien, M. B., Kollias-Baker, C., Rosenberg, M., Downing, S., Post, G., Boucher, J., Shenoy, N., Mendel, D. B. & Cherrington, J. M. (2003) Phase I dose escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. Clinical Cancer Research 9, 2755-2768
  • Ma, Y., Longley, B. J., Wang, X., Blount, J. L., Langley, K. & Caughey, G. H. (1999) Clustering of activating mutations in c-KIT’s juxtamembrane coding region in canine mast cell neoplasms. Journal of Investigative Dermatology 112, 165-170
  • McCaw, D. L., Miller, M. A. & Ogilvie, G. K. (1994) Response of canine mast cell tumours to treatment with oral prednisolone. Journal of Veterinary Internal Medicine 8, 406-408
  • McCaw, D. L., Miller, M. A. & Bergman, P. J. (1997) Vincristine therapy for mast cell tumours in dogs. Journal of Veterinary Internal Medicine 11, 375-378
  • McManus, P. M. (1999) Frequency and severity of mastocytemia in dogs with and without MCTs: 120 cases (1995 – 1997). Journal of the American Veterinary Medical Association 215, 355-357
  • McNeil, E. A., Prink, A. L., & O’Brien, T. D. (2006) Evaluation of risk and clinical outcome of mast cell tumours in pug dogs. Veterinary and Comparative Oncology 4, 2-8
  • Michels, G. M., Knapp, D. W., DeNicola, D. B., Glickman, N. & Bonney, P. (2002) Prognosis following surgical excision of canine cutaneous mast cell tumours with histopathologically tumour-free versus nontumour-free margins: a retrospective study of 31 cases. Journal of the American Animal Hospital Association 38, 458-466
  • Morini, M., Bettini, G., Preziosi, R. & Mandrioli, L. (2004) C-kit gene product (CD117) immunoreactivity in canine and feline paraffin sections. Journal of Histochemistry and Cytochemistry 52, 705-708
  • Mullins, M. N., Dernell, W. S., Withrow, S. J., Ehrhart, E. J., Thamm, D. H. & Lana, S. E. (2006) Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumours treated with surgery with and without adjuvant treatment: 54 cases (1998 – 2004). Journal of the American Veterinary Medical Association 228, 91-95
  • Murphy, S., Sparkes, A. H., Smith, K. C., Blunden, A. S. & Brearley, M. J. (2004) Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and efficacy of surgical resection. Veterinary Record 154, 743-746
  • Murphy, S., Sparkes, A. H., Blunden, A. S., Brearley, M. J. & Smith, K. C. (2006) Effects of stage and number of tumours on prognosis of dogs with cutaneous MCTs. Veterinary Record 158, 287-291
  • Neyens, I. J. S., Kirpensteijn, J., Grinwis, G. C. M. & Teske, E. (2004) Pilot study of intraregional deionised water adjunct therapy for mast cell tumours in dogs. Veterinary Record 154, 90-91
  • Northrup, N. C., Harmon, B. G., Gieger, T. L., Brown, C. A., Carmichael, K. P., Garcia, A., Latimer, K. S., Munday, J. S., Rakich, P. M., Richey, L. J., Stedman, N. L., Cheng, A. L. & Howerth, E. W. (2005a) Variation among pathologists in histologic grading of canine cutaneous mast cell tumors. Journal of Veterinary Diagnostic Investigation 17, 245-248
  • Northrup, N. C., Howerth, E. W., Harmon, B. G., Brown, C. A., Carmicheal, K. P., Garcia, A. P., Latimer, K. S., Munday, J. S., Rakich, P. M., Richey. L. J., Stedman, N. L. & Gieger, T. L. (2005b) Variation among pathologists in the histologic grading of canine cutaneous mast cell tumors with uniform use of a single grading reference. Journal of Veterinary Diagnostic Investigation 17, 561-564
  • O’Keefe, D. A., Couto, G. C., Burke-Schwartz, C. & Jacobs, R. M. (1987) Systemic mastocytosis in 16 dogs. Journal of Veterinary Internal Medicine 1, 75-80
  • Owen, L. (1980) TNM Classification of Tumours in Domestic Animals. Geneva, Switzerland: World Health Organization
  • Patnaik, A. K., Ehler, W. & MacEwan, G. (1984) Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Veterinary Pathology 21, 469-474
  • Peters, J. A. (1969) Canine mastocytoma: excess risk as related to ancestry. Journal of the National Cancer Institute 42, 435-443
  • Pryer, N. K., Lee, L. B., Zadovaskaya, R., Yu, X., Sukbuntherngh, J., Cherrington, J. M. & London, C. A. (2003) Proof of target for SU11654: inhibition of KIT phosphorylation in canine mast cell tumours. Clinical Cancer Research 9, 5729-5734
  • Rassnick, K. M., Moore, A. S. & Williams, L. E. (1999) Treatment of canine mast cell tumours with CCNU (Lomustine). Journal of Veterinary Internal Medicine 13, 601-605
  • Reguera, M. J., Rabanal, R. M., Puigdemont, A. & Ferrer, L. (2000) Canine mast cell tumors express stem cell factor receptor. American Journal of Dermatopathology 22, 49-54
  • Reguera, M. J., Ferrer, L. & Rabanal, R. M. (2002) Evaluation of an intron deletion of the c-kit gene of canine MCTs. American Journal of Veterinary Research 63, 1257-1261
  • Riva, F., Brizzola, S., Stefanello, D., Crema, S. & Turin, L. (2005) A study of mutations in the c-kit gene of 32 dogs with mastocytoma. Journal of Veterinary Diagnostic Investigation 17, 385-388
  • Scase, T. J., Edwards, D., Miller, J., Henley, W., Smith, K., Blunden, A. & Murphy, S. (2006) Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis. Journal of Veterinary Internal Medicine 20, 151-158
  • Seguin, B., Leibman, N. F., Bregazzi, V. S., Olgilvie, G. K., Powers, B. E., Dernell, W. S., Fettman, M. J. & Withrow, S. J. (2001) Clinical outcome of dogs with grade II mast cell tumours treated with surgery alone: 55 cases (1966-1999). Journal of the American Veterinary Medical Association 218, 1120-1123
  • Sfiligoi, G., Rassnick, K. M., Scarlett, J. M., Northrup, N. C. & Gieger, T. L. (2005) Outcome of dogs with mast cell tumours in the inguinal or perineal region versus other cutaneous locations 124 cases (1990 – 2001). Journal of the American Veterinary Medical Association 226, 1368-1374
  • Simoes, J. P., Schoning, P. & Butine, M. (1994) Prognosis of canine mast cell tumours: a comparison of three methods. Veterinary Pathology 31, 637-647
  • Simpson, A. M., Ludwig, L. L., Newman, S. J., Bergman, P. J., Hottinger, H. A. & Patnaik, A. K. (2004) Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs. Journal of the American Veterinary Medical Association 224, 236-240
  • Strefezzi, R. De F., Xavier, J. G. & Catao-Dias, J. L. (2003) Morphometry of canine cutaneous mast cell tumors. Veterinary Pathology 40, 268-275
  • Takahashi, T., Kadosawa, T., Nagase, M., Mochizuki, M., Matsunaga, S., Nishimura, R. & Sasaki, N. (1997) Inhibitory effects of glucocorticoids on proliferation of canine mast cell tumor. Journal of Veterinary Medical Science 59, 995-1001
  • Thamm, D., Mandlin, E. & Vail, D. (1999) Prednisone and vinblastine chemotherapy for canine mast cell tumour tumours – 41 cases (1992–1997). Journal of Veterinary Internal Medicine 13, 491-497
  • Thamm, D. H., Turek, M. M. & Vail, D. M. (2006) Outcome and prognostic factors following adjuvant prednisolone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases. Journal of Veterinary Medical Science 68, 581-587
  • Trumel, C., Bourges-Abella, N., Touron, C., Landore, D., Geffre, A., Diquelou, A., Guelfi, J. F. & Braun, J. P. (2005) Adverse haematological effects of vinblastine, prednisolone and cimetidine treatment: a retrospective study in fourteen dogs with mast cell tumours. Journal of Veterinary Medicine, Physiology, Pathology and Clinical Medicine 52, 275-279
  • Turrel, J. M., Kitchell, B. E., Miller, L. M. & Theon, A. (1988) Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. Journal of the American Veterinary Medical Association 193, 936-940
  • Webster, J. D., Kiupel, M., Kaneene, J. B., Miller, R. & Yuzbasiyan-Gurkan, V. (2004) The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Veterinary Pathology 41, 371-377
  • Webster, J. D., Yuzbasiyan-Gurkan, V., Kaneene, J. B., Miller, R., Resau, J. H. & Kiupel, M. (2006a) The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors. Neoplasia 8, 104-111
  • Webster, J. D., Kiupel, M. & Yuzbasiyan-Gurkan, V. (2006b) Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors. BMC Cancer 6, 85
  • Weisse, C., Shofer, F. S. & Sorenmo, K. (2002) Recurrence rates and sites for Grade II canine cutaneous mast cell tumours following complete surgical excision. Journal of the American Animal Hospital Association 38, 71-73
  • Zemke, D., Yamini, B. & Yuzbasiyan-Gurkan, V. (2002) Mutations in the juxtamembrane domain of c-Kit are associated with higher grade MCTs in dogs. Veterinary Pathology 39, 529-535